Target intelligence / Profile preview

DnaJ heat shock protein family member A1 (DNAJA1)

Target
DNAJA1
Molecular classification
Chaperone protein, Co-chaperone, Heat shock protein (Hsp40 family)
01

Overview

DnaJ heat shock protein family member A1 (DNAJA1) is a human protein that functions as a co-chaperone within the Hsp70 system, helping to regulate ATP hydrolysis and client substrate transfer for proper protein folding, trafficking, prevention of aggregation, and protein degradation[1][3]. Structurally, it features a highly conserved N-terminal J domain responsible for Hsp70 interaction, a glycine/phenylalanine-rich region, zinc finger motifs, and a C-terminal substrate-binding domain[1][3]. DNAJA1 participates in diverse cellular functions, including protecting cells from stress-induced apoptosis, regulating protein import into mitochondria, and is implicated in responses to viral infection and certain neurodegenerative and oncological diseases[1][3][4]. It is considered a promising, though not yet clinically validated, therapeutic target in diseases such as cancer due to its regulatory role in proteostasis and cell death pathways[3].

Other names
DnaJ (Hsp40) homolog, subfamily A, member 1HSPF4Hdj-2NEDD7Dj-2HSJ2Neural precursor cell expressed, developmentally down-regulated 7DnaJ homolog subfamily A member 1Heat shock 40 kDa protein 4
02

Mechanism of action

For potential drugs: Inhibition or modulation of the Hsp40-Hsp70 (DNAJA1–HSPA1A/B) interaction; suppression of JNK pathway phosphorylation; alteration of apoptosis signaling; stabilization of misfolded protein handling[3].

03

Biological functions

Protein foldingChaperone-mediated protein transportPrevention of protein aggregationRegulation of protein degradationRegulation of apoptosis
04

Disease associations

CancerNeurodegenerative diseaseCystic fibrosisSpinocerebellar ataxiaViral infection
05

Safety considerations

Potential for affecting cellular proteostasis and stress responses broadly, leading to cell survival or deathAs with all chaperones, targeting could have pleiotropic, non-specific impacts in normal cells[3].
06

Interacting drugs

O-phospho-L-serine

1 more in the full profile.

07

Biomarkers

Downregulation of DNAJA1 is a biomarker candidate for pancreatic cancer[3].

Beyond the preview

Go deeper on DnaJ heat shock protein family member A1 (DNAJA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DnaJ heat shock protein family member A1 (DNAJA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call